Abstract
Thalassemia patients have a high cell turnover rate due to chronic hemolysis and ineffective erythropoiesis; therefore, hyperuricemia is anticipated. This study aimed to identify the prevalence of hyperuricemia, gout and nephrolithiasis, conditions associated with serum uric acid (SUA), and urine uric acid excretion (UUA) in thalassemia patients. This was a cross-sectional study in patients aged 15 years or older at Chiang Mai University Hospital. All patients had blood and 24-h urine collection test. We enrolled 112 thalassemia patients in which 67.0% were female, 64.3% had beta thalassemia/Hb E, 76.8% were transfusion dependent, and 59.8% were post splenectomy. The median age was 29 (16–58) years. Mean SUA was 6.7 ± 2.0 mg/dl and hyperuricemia (SUA > 6.8 mg/dl) was found in 47 cases (45.2%). Intact spleen (ORs 4.3, 95%CI 1.55–12.50, p = 0.01) and lower FEuric (ORs 2.08, 95%CI 1.35–3.33, p < 0.01) were associated with hyperuricemia significantly. Seven (6.3%) had gouty arthritis and nine (8%) had microscopic hematuria, one case being confirmed nephrolithiasis. The mean UUA excretion was 981.3 ± 335.0 mg/day and UUA hyperexcretion (> 700 mg/24 h) was found in 83.3%. UUA hyperexcretion patients had renal hyperfiltration 46%, glomerular dysfunction 84%, and tubular dysfunction 7.7%. From our study, hyperuricemia was found in approximately 40% of thalassemia patients but gouty arthritis occurred only in few patients (6%). This may be explained by urinary uric hyperexcretion which is found in over 80%. The significant risk factors for hyperuricemia were intact spleen and lower fraction excretion of uric acid.
Similar content being viewed by others
References
Wasi P, Pootrakul S, Pootrakul P, Pravatmuang P, Winichagoon P, Fucharoen S (1980) Thalassemia in Thailand. Ann N Y Acad Sci 344:352–363
Bernadette Modell MD (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86(6):480–487
Panich V, Pornpatkul M, Sriroongrueng W (1992) The problem of thalassemia in Thailand. Southeast Asian J Trop Med Public Health 23(Suppl 2):1–6
Fucharoen S (2013) Anemia, thalassemia and hemogloboinopathies in Northeast Thailand, Lao PDR and Vietnam. Srinagarind med J 25
Abdelmotaleb GAM, Abdelmonaem E, Ahmed E, Aboelsoued A et al (2017) Comparative study between measurements of serum cholesterol, uric acid and glucose in children with β-thalassemia by laboratory and bedside methods. Int J Adv Res [internet] Int J Adv Res 5(6):963–973. https://doi.org/10.21474/ijar01/4498
Mishra V, Sorabjee J, Mirgh S, Mishra M (2016) Tophaceous gout in thalassemia intermedia: a rare association. Oxf Med Case Rep 2016(5):105–106. https://doi.org/10.1093/omcr/omw030
Kumar V, Gruber B (2003) Tophaceous gout in a patient with thalassemia. J Clin Rheumatol : Pract Rep Rheumatic Musculoskelet Dis 9(6):380–384. https://doi.org/10.1097/01.rhu.0000099746.74211.78
Ricchi P, Ammirabile M, Costantini S, Di Matola T, Spasiano A, Genna ML, Cinque P, Prossomariti L (2012) Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study. Blood Cells Mol Dis 49(3–4):133–135. https://doi.org/10.1016/j.bcmd.2012.05.012
Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, Messing EM, Miller SD, Peterson AC, Turk TM, Weitzel W (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188(6 Suppl):2473–2481. https://doi.org/10.1016/j.juro.2012.09.078
Neogi T (2011) Clinical practice. Gout N Engl J Med 364(5):443–452. https://doi.org/10.1056/NEJMcp1001124
Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM (2002) Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum 47(6):610–613. https://doi.org/10.1002/art.10792
Emmerson BT (1996) The Management of Gout. N Engl J Med 334(7):445–451. https://doi.org/10.1056/nejm199602153340707
Yang C-Y, Chen F-A, Chen C-F, Liu W-S, Shih C-J, Ou S-M, Yang W-C, Lin C-C, Yang A-H (2015) Diagnostic accuracy of urine protein/creatinine ratio is influenced by urine concentration. PLoS One 10(9):e0137460. https://doi.org/10.1371/journal.pone.0137460
KDIGO (2012) Clinical practice guideline for the evaluation and Management of Chronic Kidney Disease (2013). Off J Int Soc Nephrol 3(1)
Cachat F, Combescure C, Cauderay M, Girardin E, Chehade H (2015) A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clin J Am Soc Nephrol: CJASN 10(3):382–389. https://doi.org/10.2215/cjn.03080314
Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AAK, Vernekar SN (2010) Markers of renal function tests. N Am J Med Sci 2(4):170–173
Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J (2007) Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18(2):407–413. https://doi.org/10.1681/asn.2006080882
Lohsoonthorn V, Dhanamun B, Williams MA (2006) Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res 37(7):883–889. https://doi.org/10.1016/j.arcmed.2006.03.008
Arlet JB, Ribeil JA, Chatellier G, Pouchot J, de Montalembert M, Prie D, Courbebaisse M (2012) Hyperuricemia in sickle cell disease in France. Rev Med Interne / fondee par la Societe nationale francaise de medecine interne 33(1):13–17. https://doi.org/10.1016/j.revmed.2011.07.002
Melo TRFD, Ercolin LDR, Chelucci RC, Melchior ACB, Lanaro C, Chin CM, Santos JLD (2015) Sickle Cell Disease – Current Treatment and New Therapeutical Approaches. In: Munshi A (ed) Inherited Hemoglobin Disorders. InTech, Rijeka, p Ch. 09. doi:https://doi.org/10.5772/60515
Rachmilewitz EA, Giardina PJ (2011) How I treat thalassemia. Blood 118(13):3479–3488
Piga A, Serra M, Longo F, Forni G, Quarta G, Cappellini MD, Galanello R (2011) Changing patterns of splenectomy in transfusion-dependent thalassemia patients. Am J Hematol 86(9):808–810. https://doi.org/10.1002/ajh.22102
Inthawong K, Charoenkwan P, Silvilairat S, Tantiworawit A, Phrommintikul A, Choeyprasert W, Natesirinilkul R, Siwasomboon C, Visrutaratna P, Srichairatanakool S, Chattipakorn N, Sanguansermsri T (2015) Pulmonary hypertension in non-transfusion-dependent thalassemia: correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron. Hematology (Amsterdam, Netherlands) 20(10):610–617. https://doi.org/10.1179/1607845415y.0000000014
Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R (2000) The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 43:13–108. https://doi.org/10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C
Louthrenoo W, Kasitanon N, Wichainun R, Sukitawut W (2003) Effect of Minidose Aspirin on Renal Function and Renal Uric Acid Handling in Healthy Young Adults, vol 8. doi:https://doi.org/10.1097/00124743-200212000-00003,
Hyo Jin C, Yun Jong L, Jeong Jin P, Jung Chan L, Eun Young L, Eun Bong L, Yeong Wook S (2006) The effect of low dose aspirin on serum and urinary uric acid level in gouty arthritis patients. J Korean Rheum Assoc 13(3):203–208
Ali D, Mehran K, Moghaddam AG (2008) Comparative evaluation of renal findings in Beta-thalassemia major and intermedia. Saudi J Kidney Dis Transpl : Off Publ Saudi Center Organ Transplant, Saudi Arabia 19(2):206–209
Su P, Hong L, Zhao Y, Sun H, Li L (2016) The association between hyperuricemia and hematological indicators in a Chinese adult population. Medicine 95(7):e2822. https://doi.org/10.1097/md.0000000000002822
Moriwaki Y, Yamamoto T, Takahashi S, Yamakita J, Tsutsumi Z, Hada T (2001) Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout. J Rheumatol 28(6):1306–1310
Molazem Z, Noormohammadi R, Dokouhaki R, Zakerinia M, Bagheri Z (2016) The effects of nutrition, exercise, and a praying program on reducing Iron overload in patients with Beta-thalassemia major: a randomized clinical trial. Iran J Pediatr 26(5):e3869. https://doi.org/10.5812/ijp.3869
Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, Neogi T (2012) Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis 71(9):1448–1453. https://doi.org/10.1136/annrheumdis-2011-201215
Bekhit OE, El Dash HH, Ahmed MS (2017) Early detection of kidney dysfunction in Egyptian patients with beta-thalassemia major. Egypt Pediatr Assoc Gazette 65(3):85–89. https://doi.org/10.1016/j.epag.2017.02.002
Sadeghi-Bojd S, Hashemi M, Naderi M, Shikhani S (2011) Kidney function tests in children with beta-thalassemia minor in Zahedan, southeast of Iran. Iran J Kidney Dis 5(3):201–203
Holzscheiter L, Beck C, Rutz S, Manuilova E, Domke I, Guder Walter G, Hofmann W (2014) NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction. Clin Chem Lab Med 52. https://doi.org/10.1515/cclm-2013-0693
Thanakitcharu P, Jirajan B (2014) Determination of urinary neutrophil gelatinase-associated lipocalin (NGAL) cut-off level for early detection of acute kidney injury in Thai adult patients undergoing open cardiac surgery. J Med Assoc Thailand = Chotmaihet thangphaet 97(Suppl 11):S48–S55
Rostami Z, Nikpoor M, Einollahi B (2013) Urinary neutrophil gelatinase associated Lipocalin (NGAL) for early diagnosis of acute kidney injury in renal transplant recipients. Nephro-urol Monthly 5(2):745–752. https://doi.org/10.5812/numonthly.9385
Sen V, Ece A, Uluca U, Soker M, Gunes A, Kaplan I, Tan I, Yel S, Mete N, Sahin C (2015) Urinary early kidney injury molecules in children with beta-thalassemia major. Ren Fail 37(4):607–613. https://doi.org/10.3109/0886022x.2015.1007871
Deveci B, Kurtoglu A, Kurtoglu E, Salim O, Toptas T (2016) Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia. Ann Hematol 95(3):375–381. https://doi.org/10.1007/s00277-015-2561-2
Smolkin V, Halevy R, Levin C, Mines M, Sakran W, Ilia K, Koren A (2008) Renal function in children with β-thalassemia major and thalassemia intermedia. Pediatr Nephrol 23(10):1847–1851. https://doi.org/10.1007/s00467-008-0897-8
Bjornstad P, Roncal C, Harra T, Pyle L, Lanaspa MA, Bishop FK, Snell-Bergeon JK, Johnson RJ, Wadwa RP, Maahs DM (2016) Hyperfiltration and uricosuria in adolescents with type 1 diabetes. Pediatric Nephrology (Berlin, Germany) 31(5):787–793. https://doi.org/10.1007/s00467-015-3299-8
Cheung KL, Lafayette RA (2013) Renal physiology of pregnancy. Adv Chronic Kidney Dis 20(3):209–214. https://doi.org/10.1053/j.ackd.2013.01.012
Helal I, Brosnahan G, Gitomer B, Schrier R (2012) Glomerular hyperfiltration: Definitions, mechanisms and clinical implications, vol 8. doi:https://doi.org/10.1038/nrneph.2012.19
Musallam KM, Taher AT (2012) Mechanisms of renal disease in β-thalassemia. J Am Soc Nephrol 23(8):1299–1302. https://doi.org/10.1681/asn.2011111070
Quinn CT, Johnson VL, Kim HY, Trachtenberg F, Vogiatzi MG, Kwiatkowski JL, Neufeld EJ, Fung E, Oliveri N, Kirby M, Giardina PJ (2011) Renal dysfunction in patients with thalassaemia. Br J Haematol 153(1):111–117. https://doi.org/10.1111/j.1365-2141.2010.08477.x
Sumboonnanonda A, Malasit P, Tanphaichitr VS, Ong-ajyooth S, Petrarat S, Vongjirad A (2003) Renal tubular dysfunction in alpha-thalassemia. Pediatr Nephrol 18(3):257–260. https://doi.org/10.1007/s00467-003-1067-7
Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W (2015) Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015:762820–762812. https://doi.org/10.1155/2015/762820
ชัยอำนวย พ ระบาดวิทยาของโรครูมาติค. Thai arthritis foundation. https://www.thaiarthritis.org/people23.php. Accessed 27 Sept 2018
Nickavar A, Qmarsi A, Ansari S, Zarei E (2017) Kidney function in patients with different variants of Beta-thalassemia. Iran J Kidney Dis 11(2):132–137
Efthimia V, Neokleous N, Agapidou A, Economou M, Vetsiou E, Teli A, Perifanis V (2013) Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience. Ann Hematol 92(2):263–265. https://doi.org/10.1007/s00277-012-1558-3
Ricchi PAM, Costantini S, Spasiano A, Di Matola T, Cinque P et al (2013) Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters. Ann Hematol 93(3):525–527. https://doi.org/10.1007/s00277-013-1833-y
Ngo TC, Assimos DG (2007) Uric acid nephrolithiasis: recent Progress and future directions. Rev Urol 9(1):17–27
Acknowledgements
I would like to sincerely thank Ms. Antika Wongthani, Head of Analytical & Statistical data unit, Research Institute for Health Sciences, Chiang Mai University for suggestion in statistics of this study.
Funding
This study was supported by a research grant from the Faculty of Medicine, Chiang Mai University. Grant number: FUND-25591019-08194.
Author information
Authors and Affiliations
Contributions
J.C. designed the research, collected, summarized, analyzed clinical data, and wrote the paper; A.T. designed the research, obtained researched grant, analyzed data, wrote the paper, and corresponding author; T.R., E.R.,C.C., L.N., P.C. wrote, revised, and approved the final manuscript. W.L designed the research, wrote, revised manuscript, approved the final manuscript, and gave critical comment.
Corresponding author
Ethics declarations
This study was approved by the ethical research committee, Faculty of Medicine, Chiang Mai University. Study code: MED-2559-04246 and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chaloemwong, J., Tantiworawit, A., Rattanathammethee, T. et al. Hyperuricemia, urine uric excretion, and associated complications in thalassemia patients. Ann Hematol 98, 1101–1110 (2019). https://doi.org/10.1007/s00277-019-03630-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-019-03630-0